Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03485131 · ClinicalTrials.gov registry record · NA
Transcranial Direct-current Stimulation (tDCS) in Treatment Refractory Auditory Hallucinations
A NA study, sponsored by Manhattan Psychiatric Center.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT03485131 is a NA study that has completed, run by Manhattan Psychiatric Center. The registered enrollment target is 27 participants.
The verdict
NCT03485131, a NA study, has completed, sponsored by Manhattan Psychiatric Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
This is a 4 week therapeutic pilot study with a 4 week follow-up period involving inpatients with treatment resistant DSM-IV schizophrenia or schizoaffective disorder diagnosis. Each eligible subject will receive either 20 minutes of active tDCS (transcranial direct-current stimulation) or sham stimulation twice a day on 5 consecutive weekdays for 4 weeks with a 4 week follow-up period.
Interventions
- DEVICE Placebo
- DEVICE Transcranial direct-current stimulation (tDCS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2014-04 |
| Est. Completion | 2018-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03485131
The ClinicalTrials.gov registry entry for NCT03485131 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Manhattan Psychiatric Center, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03485131 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03485131 about?
NCT03485131 is a clinical study titled "Transcranial Direct-current Stimulation (tDCS) in Treatment Refractory Auditory Hallucinations". This is a 4 week therapeutic pilot study with a 4 week follow-up period involving inpatients with treatment resistant DSM-IV schizophrenia or schizoaffective disorder diagnosis. Each eligible subject will receive either 20 minutes of active tDCS (transcranial direct-current stimulation) or sham stim...
What is the current status of trial NCT03485131?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2014-04. Estimated completion is 2018-03.
What interventions are being tested in trial NCT03485131?
The interventions under investigation include: Placebo (DEVICE), Transcranial direct-current stimulation (tDCS) (DEVICE).
Who is sponsoring clinical trial NCT03485131?
This trial is sponsored by Manhattan Psychiatric Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.